MedPath

4D Velocity Mapping of the Heart in rTOF Patients

Not Applicable
Conditions
Magnetic Resonance Imaging
Tetralogy of Fallot
Registration Number
NCT02980614
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its branches inside the same sequence.

Detailed Description

MRI with 4D flow permits to assess the hemodynamic parameters in a parent vessel and its branches inside the same sequence. The objective of the project is to compare the regurgitant fraction in the pulmonary artery (PA) measured using 4D MR-flow and standard 2D MR-flow in repaired Tetralogy of Fallot (rTOF) patients. The consistency of the 4D flow quantization will be assessed assuming mass conservation in the pulmonary artery tree (PA flow =LeftPA flow +RightPA flow ? ).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Tetralogy of Fallot patients
  • referred for clinical MRI examination
  • ≥ 15 years
Exclusion Criteria
  • Anyone with a classic contraindication to MRI
  • Severe obesity
  • Gadolinium chelate allergy
  • < 15 years
  • counter-indication to MRI examination
  • vulnerable person

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Regurgitant fraction comparisonDay 0

The primary objective of the project is to compare the regurgitant fraction in the pulmonary artery (PA) measured with 4D MR-flow and standard 2D MR-flow.

Secondary Outcome Measures
NameTimeMethod
Pulmonary arteries flowsDay 0

The consistency of the 4D flow quantization will be assessed assuming mass conservation in the pulmonary artery (PA) tree (PA flow =LeftPA flow +RightPA flow ? ).

Right ventricular volumeDay 0

The secondary objective is to compare the right ventricular volumes measured using the 4D prototype and the standard steady-state free precession sequences.

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

CHU Amiens
🇫🇷Amiens, France
Cedric Renard, MD
Contact
+33 3 22 08 75 37
renard.cedric@chu-amiens.fr
Amel Mathiron, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.